11/16/2026
STILL HUNGRY ON RETATRUTIDE?
You've probably heard that GLP-1 medications help reduce appetite. But what if you're still feeling hungry during treatment? Some people taking retatrutide report exactly that, and its mechanism may help explain why.
Unlike traditional GLP-1 medications, it acts on 3 receptors, GLP-1, GIP and glucagon, and the glucagon part works on how much energy the body uses, not only on appetite.
In this video, we explain why that matters for anyone comparing weight loss options.
Retatrutide is still investigational and not approved by the FDA. Questions about weight management? Start with a consultation.
📍 Beverly Hills | 📞 (310) 407-0542 | 💻 rwacenter.com